This application is a component of an Interactive Research Project Grant (IRPG) composed of four interrelated projects (including: Sealfon, PI, Maayani, PI. and Martinelli, PI) aimed at understanding the mechanisms of action of hallucinogenic drugs of abuse at the cellular/molecular level of detail. The common underlying hypothesis is that the hallucinogenic potential of certain compounds reflects specific, identifiable differences from congeneric non-hallucinogens in the molecular mechanisms of ligand/receptor interaction and in the structural and dynamic response of the receptors to these interactions (e.g., as reflected in the ensuing effector-coupling and desensitization mechanisms). This hypothesis leads to the proposed investigations of the molecular details of the discriminant factors responsible for the special properties underlying the actions of hallucinogenic drugs of abuse. The collaborative efforts include structure-function explorations by modifications of the same set of specific 5-HT receptors on which hallucinogenic molecules act, and coordinated assessments of discriminant pharmacological characteristics and interactions of hallucinogens. To achieve the goals of the theoretical components of this IRPG the following interrelated steps will be taken: 1. We will construct complete three dimensional molecular models of the 5-HT2 and 5-HT1C receptors and their complexes with hallucinogens and non- hallucinogens. 2. We will simulate the dynamics of ligand/receptor complexes with the models of the 5-HT2 and 5-HT1C receptors in order to examine the time-dependent elements of the receptor recognition process for agonist vs. antagonist pairs, and hallucinogen vs. non-hallucinogen pairs, and in order to identify the time-dependent changes in receptor structure related to the signal transduction mechanisms induced by the various pairs of compounds. 3. We will explore with computational modeling and dynamic simulation the structural basis for the special interaction properties of the 5-HT6 receptor with hallucinogenic compounds in the class of """"""""tricyclic psychotropic drugs"""""""" for which it was shown to have high affinity, and with structurally cognate nonhallucinogens. Structure- function relations of both the ligands and the receptors will be explored in the theoretical constructs and, in parallel, experimentally. Mutant receptor constructs and pharmacological assays suggested by the results of the computational studies will be performed in the proposed shared Core facilities of the IRPG. In addition, proposed collaborative studies will take advantage of the insights developed from the receptor models and computational simulations to study directly the mechanistic basis of any pharmacologically defined discrimination between the actions of hallucinogens and structurally related non-hallucinogens on the receptors, including the structural determinants (of the receptors and of the ligands), as well as measurable consequences of receptor/effector coupling (e.g., relative efficacy and desensitization) and the mechanisms of cross- amplification of the actions of various receptor/effector systems.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA009083-04
Application #
2458417
Study Section
Drug Abuse Biomedical Research Review Committee (DABR)
Project Start
1994-08-15
Project End
1999-07-31
Budget Start
1997-08-01
Budget End
1998-07-31
Support Year
4
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Mount Sinai School of Medicine
Department
Physiology
Type
Schools of Medicine
DUNS #
114400633
City
New York
State
NY
Country
United States
Zip Code
10029
Visiers, Irache; Ballesteros, Juan A; Weinstein, Harel (2002) Three-dimensional representations of G protein-coupled receptor structures and mechanisms. Methods Enzymol 343:329-71
Hassan, Sergio A; Mehler, Ernest L (2002) A critical analysis of continuum electrostatics: the screened Coulomb potential--implicit solvent model and the study of the alanine dipeptide and discrimination of misfolded structures of proteins. Proteins 47:45-61
Rosendorff, A; Ebersole, B J; Sealfon, S C (2000) Conserved helix 7 tyrosine functions as an activation relay in the serotonin 5HT(2C) receptor. Brain Res Mol Brain Res 84:90-6
Campagne, F (2000) Clustalnet: the joining of Clustal and CORBA. Bioinformatics 16:606-12
Javitch, J A; Shi, L; Simpson, M M et al. (2000) The fourth transmembrane segment of the dopamine D2 receptor: accessibility in the binding-site crevice and position in the transmembrane bundle. Biochemistry 39:12190-9
Campagne, F; Weinstein, H (1999) Schematic representation of residue-based protein context-dependent data: an application to transmembrane proteins. J Mol Graph Model 17:207-13
Konvicka, K; Guarnieri, F; Ballesteros, J A et al. (1998) A proposed structure for transmembrane segment 7 of G protein-coupled receptors incorporating an asn-Pro/Asp-Pro motif. Biophys J 75:601-11
Javitch, J A; Ballesteros, J A; Weinstein, H et al. (1998) A cluster of aromatic residues in the sixth membrane-spanning segment of the dopamine D2 receptor is accessible in the binding-site crevice. Biochemistry 37:998-1006
Gether, U; Ballesteros, J A; Seifert, R et al. (1997) Structural instability of a constitutively active G protein-coupled receptor. Agonist-independent activation due to conformational flexibility. J Biol Chem 272:2587-90
Gether, U; Lin, S; Ghanouni, P et al. (1997) Agonists induce conformational changes in transmembrane domains III and VI of the beta2 adrenoceptor. EMBO J 16:6737-47

Showing the most recent 10 out of 14 publications